Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1594997

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1594997

Protein Sequencing

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Protein Sequencing Market to Reach US$1.5 Billion by 2030

The global market for Protein Sequencing estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis period. Growth in the Edman Degradation Technology segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$338.6 Million While China is Forecast to Grow at 2.7% CAGR

The Protein Sequencing market in the U.S. is estimated at US$338.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$244.9 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Protein Sequencing Market - Key Trends & Drivers Summarized

What Is Protein Sequencing and Why Is It Essential?

Protein sequencing is the analytical process used to determine the amino acid sequence of proteins, unlocking crucial information about their structure and function. The primary techniques utilized in protein sequencing include Edman degradation and mass spectrometry, which allow researchers to identify, characterize, and study protein compositions in complex biological samples. Understanding protein sequences provides insights into cellular processes, disease mechanisms, and genetic expression, making this technology a cornerstone in biotechnology and pharmaceutical research. Beyond basic science, protein sequencing also plays a pivotal role in developing targeted therapies, vaccines, and diagnostic tools. By identifying the exact structure and sequence of proteins, researchers and clinicians can pinpoint biomarkers associated with specific diseases, enabling more personalized approaches in medicine. The scope of protein sequencing has expanded from foundational studies of protein function to applications in proteomics, immunology, and synthetic biology. With each breakthrough, protein sequencing reveals new complexities of biological systems, offering a deeper understanding of how proteins govern the essential processes of life.

How Are Technological Innovations Shaping Protein Sequencing?

Recent technological advancements have significantly enhanced the speed, accuracy, and affordability of protein sequencing, transforming it into a high-throughput process. Traditional Edman degradation, while precise, was slow and limited in scope, but today’s mass spectrometry-based methods can process large protein datasets rapidly. Innovations such as tandem mass spectrometry (MS/MS) allow researchers to sequence peptides by breaking them down into smaller fragments, providing more detailed and comprehensive data. Furthermore, advancements in machine learning and bioinformatics have enabled more effective analysis of large-scale protein data, enhancing the ability to map proteins with high fidelity. Emerging techniques, including nanopore sequencing and next-generation sequencing (NGS)-based proteomics, promise further accuracy and scope, pushing the boundaries of what protein sequencing can achieve. With the ongoing miniaturization of sequencing instruments and the integration of AI-based analysis, protein sequencing is becoming more accessible and applicable to diverse scientific fields. These advancements are particularly impactful in pharmaceutical research and personalized medicine, where rapid, accurate protein identification can accelerate drug discovery and precision diagnostics.

Who Is Driving the Demand for Protein Sequencing Solutions?

The demand for protein sequencing technologies is being driven by a wide range of applications across industries, including biotechnology, pharmaceuticals, and environmental research. Pharmaceutical companies are leveraging protein sequencing to discover novel therapeutic targets and to characterize biologics like monoclonal antibodies, which are crucial in cancer and autoimmune disease treatment. In agricultural biotechnology, protein sequencing helps develop pest-resistant crops and more efficient enzyme solutions for food processing. The field of immunology also benefits from protein sequencing, as it enables the study of immune system proteins, which is fundamental in vaccine development and autoimmune disease research. Environmental scientists utilize protein sequencing to study microbial ecosystems, gaining insights into biodiversity and bioremediation processes. The clinical diagnostics industry also represents a major consumer of protein sequencing, where it is used to identify disease-specific biomarkers for more accurate diagnoses. Overall, the applications of protein sequencing are expanding rapidly, as this technology provides solutions that span multiple fields, each requiring precise and actionable protein information.

What Factors Are Driving Growth in the Protein Sequencing Market?

The protein sequencing market is expanding rapidly due to a combination of technological, commercial, and societal factors. Advances in next-generation sequencing (NGS) technology, coupled with increasing computational capabilities, are enabling more rapid and cost-effective sequencing than ever before. The demand from pharmaceutical and biotechnology industries for high-throughput sequencing for drug discovery and development is a major driver, particularly as biologics and biosimilars gain popularity as therapeutic agents. Consumer demand for precision medicine is also contributing to market growth, as protein sequencing is fundamental in identifying patient-specific protein profiles that inform targeted treatment options. Additionally, the surge in academic and clinical research related to proteomics and genomics is stimulating the need for innovative sequencing methods that can provide comprehensive protein analysis. Furthermore, the increasing prevalence of chronic diseases and the growing need for personalized treatments are driving investment in proteomics, where protein sequencing plays an indispensable role. Lastly, supportive government policies and funding in the fields of biotechnology and personalized healthcare are accelerating adoption across research institutions and private sector organizations. Together, these factors underscore the critical role of protein sequencing in advancing scientific and clinical capabilities, ensuring its continued growth and relevance in the years ahead.

SCOPE OF STUDY:

The report analyzes the Protein Sequencing market in terms of US$ Thousand by the following Application; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Technology (Mass Spectrometry, Edman Degradation); Application (Biotherapeutics, Genetic Engineering, Other Applications); End-Use (Academic Institutes & Research Centers, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Agilent Technologies
  • Bioinformatics Solution
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor
  • Selvita
  • SGS (SA)
  • Shimadzu Corp.
  • Thermo Fischer Inc.
  • Water Corporation
Show more
Product Code: MCP22661

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Protein Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Precision Medicine and Personalized Therapies Drives Growth in Protein Sequencing Technologies
    • Rising Use of Protein Sequencing in Drug Discovery and Development Expands Addressable Market for Biotechnology and Pharma Applications
    • Advances in Mass Spectrometry and High-Throughput Sequencing Propel Innovations and Efficiency in Protein Sequencing Processes
    • Growing Need for Proteomic Data to Understand Complex Diseases Spurs Adoption of Protein Sequencing in Biomedical Research
    • Integration of Artificial Intelligence and Machine Learning in Protein Sequencing Enhances Data Analysis, Accuracy, and Predictive Insights
    • Expanding Applications of Protein Sequencing in Biomarker Discovery Accelerates Demand in Cancer, Cardiovascular, and Neurological Disease Studies
    • Increasing Prevalence of Chronic Diseases and Personalized Treatment Approaches Drive Market Growth for Advanced Protein Analysis Techniques
    • Miniaturization and Automation of Protein Sequencing Tools Generate Opportunities for Point-of-Care Diagnostics and Clinical Applications
    • Rising Demand for Proteomic Data in Agricultural Biotechnology Propels Use of Protein Sequencing in Crop and Livestock Improvement Programs
    • Growing Adoption of Next-Generation Sequencing (NGS) and Single-Molecule Sequencing Drives Technological Advancements in Protein Sequencing
    • Increased Awareness of Protein Sequencing in Environmental and Marine Biology Expands Applications Beyond Traditional Life Sciences
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Edman Degradation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Biotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Protein Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!